193 related articles for article (PubMed ID: 14658416)
1. Nicorandil for angina--an update.
Drug Ther Bull; 2003 Nov; 41(11):86-8. PubMed ID: 14658416
[TBL] [Abstract][Full Text] [Related]
2. Nicorandil for angina.
Drug Ther Bull; 1995 Dec; 33(12):89-92. PubMed ID: 8777891
[TBL] [Abstract][Full Text] [Related]
3. Nicorandil: a review of its use in the management of stable angina pectoris, including high-risk patients.
Simpson D; Wellington K
Drugs; 2004; 64(17):1941-55. PubMed ID: 15329045
[TBL] [Abstract][Full Text] [Related]
4. Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectoris.
Frampton J; Buckley MM; Fitton A
Drugs; 1992 Oct; 44(4):625-55. PubMed ID: 1281076
[TBL] [Abstract][Full Text] [Related]
5. [Systematic review on the short-term efficacy and safety of nicorandil for stable angina pectoris in comparison with those of β-blockers, nitrates and calcium antagonists].
Hanai Y; Mita M; Hishinuma S; Shoji M
Yakugaku Zasshi; 2010 Nov; 130(11):1549-63. PubMed ID: 21048416
[TBL] [Abstract][Full Text] [Related]
6. Nicorandil. An updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effects.
Markham A; Plosker GL; Goa KL
Drugs; 2000 Oct; 60(4):955-74. PubMed ID: 11085202
[TBL] [Abstract][Full Text] [Related]
7. Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial.
IONA Study Group
Lancet; 2002 Apr; 359(9314):1269-75. PubMed ID: 11965271
[TBL] [Abstract][Full Text] [Related]
8. Impact of nicorandil in angina: subgroup analyses.
IONA Study Group
Heart; 2004 Dec; 90(12):1427-30. PubMed ID: 15547020
[TBL] [Abstract][Full Text] [Related]
9. Trial to show the impact of nicorandil in angina (IONA): design, methodology, and management.
IONA Study Group
Heart; 2001 Jun; 85(6):E9. PubMed ID: 11359763
[TBL] [Abstract][Full Text] [Related]
10. Vasodilator Therapy: Nitrates and Nicorandil.
Tarkin JM; Kaski JC
Cardiovasc Drugs Ther; 2016 Aug; 30(4):367-378. PubMed ID: 27311574
[TBL] [Abstract][Full Text] [Related]
11. Determinants of coronary events in patients with stable angina: results from the impact of nicorandil in angina study.
IONA Study Group
Am Heart J; 2005 Oct; 150(4):689. PubMed ID: 16209965
[TBL] [Abstract][Full Text] [Related]
12. Effects of mitochondrial ATP-sensitive potassium channel activation (nicorandil) in patients with angina pectoris undergoing elective percutaneous coronary interventions: A meta-analysis of randomized controlled trials.
Zhu H; Xu X; Fang X; Zheng J; Chen T; Huang J
Medicine (Baltimore); 2019 Jan; 98(3):e14165. PubMed ID: 30653160
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic therapy of angina pectoris.
Zavecz JH; Bueno O
J La State Med Soc; 1995 May; 147(5):208-10, 213-6. PubMed ID: 7782675
[TBL] [Abstract][Full Text] [Related]
14. Lack of antagonism between nicorandil and sulfonylurea in stable angina pectoris.
Hata N; Takano M; Kunimi T; Kishida H; Takano T
Int J Clin Pharmacol Res; 2001; 21(1):59-63. PubMed ID: 11708575
[TBL] [Abstract][Full Text] [Related]
15. The role of nicorandil in the treatment of myocardial ischaemia.
Falase B; Easaw J; Youhana A
Expert Opin Pharmacother; 2001 May; 2(5):845-56. PubMed ID: 11336627
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of Anti-Ischemic and Cardioprotective Effects of Nicorandil in Patients With Stable Angina].
Rezvanova YA; Adamchik AS
Kardiologiia; 2015; 55(8):21-5. PubMed ID: 26761967
[TBL] [Abstract][Full Text] [Related]
17. Economic evaluation of the impact of nicorandil in angina (IONA) trial.
Walker A; McMurray J; Stewart S; Berger W; McMahon AD; Dargie H; Fox K; Hillis S; Henderson NJ; Ford I
Heart; 2006 May; 92(5):619-24. PubMed ID: 16614274
[TBL] [Abstract][Full Text] [Related]
18. A double-blind comparison of the long-term efficacy of a potassium channel opener and a calcium antagonist in stable angina pectoris.
Guermonprez JL; Blin P; Peterlongo F
Eur Heart J; 1993 Jul; 14 Suppl B():30-4. PubMed ID: 8370370
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of oral nicorandil in patients with end-stage renal disease: a retrospective chart review after coronary angioplasty in Japanese patients receiving hemodialysis.
Ishii H; Toriyama T; Aoyama T; Takahashi H; Yamada S; Kasuga H; Ichimiya S; Kanashiro M; Mitsuhashi H; Maruyama S; Matsuo S; Naruse K; Matsubara T; Murohara T
Clin Ther; 2007 Jan; 29(1):110-22. PubMed ID: 17379051
[TBL] [Abstract][Full Text] [Related]
20. Management of vasospastic angina--role of nicorandil.
Kaski JC
Cardiovasc Drugs Ther; 1995 Mar; 9 Suppl 2():221-7. PubMed ID: 7647026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
